La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Healthia Croissance future
Future contrôle des critères 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Healthia.
Informations clés
n/a
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
Healthcare croissance des bénéfices | 17.0% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | None |
Dernière mise à jour | n/a |
Mises à jour récentes de la croissance future
Recent updates
Calculating The Fair Value Of Healthia Limited (ASX:HLA)
Jan 30Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02
Mar 02Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise
Nov 09Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%
Sep 17Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable
Sep 17Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025
Sep 01I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease
Aug 17Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?
May 19Is Healthia (ASX:HLA) A Risky Investment?
Apr 19With EPS Growth And More, Healthia (ASX:HLA) Is Interesting
Apr 03Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year
Mar 19Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares
Mar 06What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?
Feb 26Is There Now An Opportunity In Healthia Limited (ASX:HLA)?
Feb 09Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 19Why Dividend Hunters Love Healthia Limited (ASX:HLA)
Dec 29Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?
Dec 10We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings
Nov 20Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Healthia n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.
Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
6/30/2023 | 253 | 5 | 15 | 23 | N/A |
3/31/2023 | 242 | 3 | 14 | 20 | N/A |
12/31/2022 | 232 | 1 | 12 | 18 | N/A |
9/30/2022 | 216 | -1 | 13 | 18 | N/A |
6/30/2022 | 200 | -3 | 14 | 17 | N/A |
3/31/2022 | 184 | -2 | 13 | 16 | N/A |
12/31/2021 | 168 | 0 | 12 | 15 | N/A |
9/30/2021 | 152 | 3 | 18 | 21 | N/A |
6/30/2021 | 137 | 5 | 23 | 26 | N/A |
3/31/2021 | 121 | 6 | 26 | 28 | N/A |
12/31/2020 | 105 | 7 | 29 | 31 | N/A |
9/30/2020 | 96 | 5 | 22 | 24 | N/A |
6/30/2020 | 87 | 3 | 16 | 17 | N/A |
3/31/2020 | 83 | 1 | 9 | 10 | N/A |
12/31/2019 | 79 | 0 | 2 | 3 | N/A |
9/30/2019 | 72 | 0 | -1 | 1 | N/A |
6/30/2019 | 65 | -1 | -4 | -2 | N/A |
3/31/2019 | 57 | -2 | -3 | 0 | N/A |
12/31/2018 | 48 | -3 | -1 | 2 | N/A |
9/30/2018 | 41 | -2 | -1 | 1 | N/A |
6/30/2018 | 34 | -2 | 0 | 1 | N/A |
6/30/2017 | 67 | 4 | N/A | N/A | N/A |
6/30/2016 | 67 | 4 | N/A | N/A | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if HLA's forecast earnings growth is above the savings rate (2.1%).
Bénéfices vs marché: Insufficient data to determine if HLA's earnings are forecast to grow faster than the Australian market
Croissance élevée des bénéfices: Insufficient data to determine if HLA's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if HLA's revenue is forecast to grow faster than the Australian market.
Croissance élevée des revenus: Insufficient data to determine if HLA's revenue is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if HLA's Return on Equity is forecast to be high in 3 years time